Bevacizumab for Metastatic Colorectal Cancer with Chromosomal Instability: Cost-Effectiveness Analysis for a Novel Precision Treatment Approach in Germany, Ireland and Spain

PharmacoEconomics 2026 Open access

Read full text
Authors: Jonathan Briody, Ian S. Miller, James F. O’Mahony, Lesley Tilson, Alice C. O’Farrell, Qiushi Chen, Verena Murphy, Orla M. Casey, Nadine Schulte, Matthias P. Ebert, Jochen H. M. Prehn, Diether Lambrechts
+4 more Bauke Ylstra, Rodrigo Dienstmann, Annette T. Byrne, Kathleen Bennett
DOI: 10.1007/s40273-025-01585-x
Cited by: 0
References: 62

Fields of Study & Subjects

Health Systems Economic Evaluations Quality of Life Colorectal Cancer Treatments and Studies Economic and Financial Impacts of Cancer

Publication details

Journal / source
PharmacoEconomics
Volume
44
Issue
3
Pages
359–374
Publication date
4 February 2026
Language
EN